Denny Xu
About Denny
Denny Xu focuses his practice on corporate and securities law, representing public and private companies in a variety of corporate matters ranging from mergers and acquisitions, venture financings, public offerings and corporate governance, particularly in the technology and life sciences industries.
Experience
-
Cooley Advises on Keros’ Strategic Review Process, Negotiated Share Repurchase Transactions and Planned Issuer Tender Offer
-
InnoCare Pharma and Zenas BioPharma Announce License Agreement
-
LB Pharmaceuticals Announces $285 Million Upsized IPO
-
MaxCyte – $202 Million IPO
-
Verve Therapeutics – $307 Million IPO
Related news and events
Admissions and credentials
- Massachusetts
Related services
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.